GenScript Executive and Leadership Team

Patrick Liu, the Acting Chief Executive Officer, ProBio at GenScript, spearheads the strategic direction and operational execution for the ProBio division. This leadership role involves driving innovation and market penetration within the biologics contract development and manufacturing organization (CDMO) platform. Patrick Liu oversees the integration of services and products, ensuring seamless delivery to clients and fostering advancements in biopharmaceutical development. The Acting Chief Executive Officer, ProBio's focus includes enhancing manufacturing capabilities, expanding service offerings, and ensuring regulatory compliance. By guiding the ProBio team, Patrick Liu directly impacts GenScript's ability to provide one-stop solutions to global research communities and strengthens its position as a leading biotech company.

Phil Zhou, the Chief Financial Officer at GenScript, directs all financial operations and strategic fiscal planning. Overseeing the company's financial health, the Chief Financial Officer ensures robust capital management and drives profitability across all business units. This leadership position involves optimizing resource allocation to support GenScript's four core platforms: life-science services and products, biologics CDMO, industrial synthetic products, and integrated global cell therapy. By maintaining stringent financial controls and identifying key investment opportunities, Phil Zhou directly contributes to the company's expansion and market leadership in the global life sciences sector. The Chief Financial Officer's oversight extends to budgeting, forecasting, and investor relations, solidifying GenScript's financial stability and growth trajectory.

Josie Zhou, the Interim Chief Financial Officer & Vice President, Finance at GenScript, manages immediate financial directives and oversees the finance department's day-to-day operations. This critical role ensures continuity in financial reporting and strategic fiscal oversight during the interim period. The Vice President, Finance supports the broader financial strategy, focusing on efficient resource deployment and financial compliance across GenScript's diverse service and product platforms. Josie Zhou's responsibilities include managing accounting functions, financial analysis, and supporting the company's growth initiatives. By ensuring accurate financial data and implementing effective financial controls, the Interim Chief Financial Officer & Vice President, Finance plays a vital part in maintaining the company's operational integrity and supporting its mission to serve global research communities.

Ray Chen, the President, Life Science Group at GenScript, directs the strategic growth and operational excellence of the company's core life science services and products platform. This executive leadership position involves overseeing the development and delivery of innovative solutions that empower global research communities. Ray Chen's responsibilities include expanding market reach, enhancing product portfolios, and ensuring customer satisfaction across diverse scientific disciplines. The President, Life Science Group drives initiatives that align with GenScript's mission to provide comprehensive, one-stop solutions. By fostering collaboration and leveraging cutting-edge technologies, Ray Chen ensures the Life Science Group remains at the forefront of scientific advancement and contributes significantly to the company's overall success.

Sally Wang, the President at GenScript, holds a pivotal leadership position overseeing key strategic initiatives and operational functions across the organization. This role involves driving the company's overall business objectives and ensuring alignment with its mission to provide world-class life science services and products. Sally Wang's leadership focuses on enhancing GenScript's market presence and fostering innovation within its diverse platforms, including the biologics CDMO and industrial synthetic products. By guiding cross-functional teams and championing strategic partnerships, the President ensures efficient resource utilization and sustained growth. Sally Wang's contributions are essential to maintaining GenScript's status as a global leader in the biotech industry.

Patrick L., the President, Biosciences Group at GenScript, leads the strategic development and operational management of the company's biosciences division. This executive role focuses on advancing GenScript's capabilities in areas such as cell therapy and other cutting-edge biological research services. Patrick L. oversees the integration of scientific advancements and market needs, ensuring the Biosciences Group delivers high-impact solutions to researchers worldwide. The President, Biosciences Group drives innovation, manages key research and development pipelines, and fosters collaborations that expand GenScript's scientific reach. By directing the strategic vision for the Biosciences Group, Patrick L. significantly contributes to the company's mission of empowering scientific discovery and therapeutic development.

Luquan Wang, the Executive Director and President at GenScript, provides critical leadership and strategic direction across the company's global operations. This senior executive role involves overseeing major business units and ensuring the effective implementation of corporate strategies. Luquan Wang's responsibilities encompass driving growth, fostering innovation, and maintaining GenScript's competitive edge in the life sciences sector. The Executive Director and President champions initiatives that enhance the company's integrated platforms, including its biologics CDMO and industrial synthetic products. By guiding strategic decision-making and operational efficiency, Luquan Wang plays a crucial role in advancing GenScript's mission to serve the global research community and solidify its position as a leading biotech provider.

Janice Jin, the Division President, Life Science Group, Genscript (APAC) at GenScript, directs the strategic expansion and operational management of the Life Science Group within the Asia-Pacific region. This leadership role focuses on tailoring GenScript's comprehensive life science services and products to meet the specific needs of the APAC research community. Janice Jin oversees market development, customer engagement, and the delivery of innovative solutions across the region. The Division President, Life Science Group, Genscript (APAC) ensures seamless integration of global strategies with local market dynamics, driving growth and enhancing GenScript's presence. By leading the APAC team, Janice Jin significantly contributes to the company's mission of empowering scientific discovery worldwide.